The expression of toll-like receptor 8 and its relationship with VEGF and Bcl-2 in cervical cancer

International Journal of Medical Sciences

Volumn 11, Issue 6, 2014, Pages 608-613

  Zhang, Yun ^a   Yang, Heng ^a   Barnie, Prince Amoah ^a   Yang, Peifang ^b   Su, Zhaoliang ^a   Chen, Jianguo ^b   Jiao, Zhijun ^b   Lu, Liwei ^c   Wang, Shengjun ^a   Xu, Huaxi ^a  

^a JIANGSU UNIVERSITY   (China)

^b AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Bcl 2; Human cervical cancer; TLR8; VEGF

Indexed keywords

CYCLOOXYGENASE 2; MESSENGER RNA; PROTEIN BCL 2; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR AGONIST; VASCULOTROPIN; TLR8 PROTEIN, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CELL; CANCER PATIENT; CELL CYCLE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; EPIFLUORESCENCE MICROSCOPY; FEMALE; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; UTERINE CERVIX CARCINOMA; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; HELA CELL LINE; PATHOLOGY; UTERINE CERVIX TUMOR;

APOPTOSIS; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; PROTO-ONCOGENE PROTEINS C-BCL-2; TOLL-LIKE RECEPTOR 8; UTERINE CERVICAL NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84899138215     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.8428     Document Type: Article

References (23)

1. Daud II, Scott ME, Ma Y, et al. Association between toll-like receptor expression and human papillomavirus type 16 persistence. Int J Cancer. 2011; 128:879-86.
2. Heil F, Hemmi H, Hochrein H, et al. Species-specific recognition of single- stranded RNA via Toll-like receptor 7 and 8. Science. 2004; 303:1526-9.
3. Wang L, Dai SZ, Chu HJ, et al. Integration sites and genotype distributions of human papillomavirus in cervical intraepithelial neoplasia. Asian Pac J Cancer Prev. 2013; 14:3837-41.
4. Shen XH, Liu SH. Human papillomavirus genotypes associated with mucopurulent cervicitis and cervical cancer in hangzhou, china. Asian Pac J Cancer Prev. 2013; 14:3603-6.
5. Zheng B, Morgan ME, van de Kant HJ, et al. Transcriptional modulation of pattern recognition receptors in acute colitis in mice. Biochim Biophys Acta. 2013 Dec;1832(12):2162-72.
6. Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation. Nature. 2008; 454:436-44.
7. Gribar SC, Richardson WM, Sodhi CP, et al. No longer an innocent bystander: epithelial toll-like receptor signaling in the development of mucosal inflammation. Mol Med. 2008; 14:645-59.
8. Sato Y, Goto Y, Narita N, et al. Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment. Cancer Microenviron. 2009; 2: 205-14.
9. Cherfils-Vicini J, Platonova S, Gillard M, et al. Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance. J Clin Invest. 2010; 120:1285-97.
10. Xue Y, Yang Y, Su Z, et al. Local delivery of T-bet shRNA reduces inflammation in collagen II-induced arthritis via downregulation of IFN-γ and IL-17. Mol Med Rep. 2014; 9:899-903.
11. Reynolds JM, Dong C. Toll-like receptor regulation of effector T lymphocyte function. Trends Immunol. 2013; S1471-4906(13)00093-8.
12. Liang J, Fu J, Kang H, et al. The stimulatory effect of TLRs ligands on maturation of chicken bone marrow-derived dendritic cells. Vet Immunol Immunopathol. 2013; S0165-2427(13)00196-7.
13. Renga B, Mencarelli A, Cipriani S, et al. The bile acid sensor FXR is required for immune-regulatory activities of TLR-9 in intestinal inflammation. PLoS One. 2013; 8:e54472.
14. Ma Y, Li J, Chiu I, et al. Toll-like receptor 8 functions as a negative regulator of neurite outgrowth and inducer of neuronal apoptosis. J Cell Biol. 2006; 175:209-15.
15. Gorden KK, Qin XX, Binsfeld CC, et al. Cutting edge: activation of murine TLR8 by a combination of imidazoquinoline immune response modifiers and polyT oligodeoxynucleotides. J Immunol. 2006; 177:6584-7.
16. Demaria O, Pagni PP, Traub S, et al. TLR8 deficiency leads to autoimmunity in mice. J Clin Invest. 2010; 120:3651-62.
17. Zhou Q, Zhu K, Cheng H. Tool-Like receptors in Human Papillomavirus Infection. Arch Immunol Ther. 2013; 61:203-15.
18. Lu H, Dietsch GN, Matthews MA, et al. VTX-2337 Is a Novel TLR8 Agonist That Activates NK Cells and Augments ADCC. Clinical Cancer Res. 2011; 18:499-509.
19. Zhang M, Shan H, Chang P, et al. Hydrogen sulfide offers neuroprotection on traumatic brain injury in parallel with reduced apoptosis and autophagy in mice. PLoS One. 2014; 9:e87241.
20. Koh YW, Park C, Yoon DH, et al. Prognostic Significance of COX-2 Expression and Correlation With Bcl-2 and VEGF Expression, Microvessel Density, and Clinical Variables in Classical Hodgkin Lymphoma. Am J Surg Pathol. 2013; 37:1242-51.
21. Kumar MM, Adurthi S, Ramachandran S, et al. Toll-like receptors 7, 8, and 9 expression and function in primary human cervical cancer Langerhans cells: evidence of anergy. Int J Gynecol Cancer. 2013; 23:184-92.
22. Riddell JR, Maier P, Sass SN, et al. Peroxiredoxin 1 stimulates endothelial cell expression of VEGF via TLR4 dependent activation of HIF-1α. PLoS One. 2012; 7:e50394.
23. Zhou S, Yang Y, Yang Y, et al. Combination Therapy of VEGF-Trap and Gemcitabine Results in Improved Anti-Tumor Efficacy in a Mouse Lung Cancer Model. PLoS One. 2013; 8: e68589.